Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24(+)CD38(hi) B Cells

Type I interferon is widely used for antiviral therapy, yet has yielded disappointing results toward chronic HBV infection. Here we identify that PEG-IFNα-2b therapy toward persistent infection in humans is a double-edged sword of both immunostimulation and immunomodulation. Our studies of this rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Binqing, Wang, Dongyao, Shen, Xiaokun, Guo, Chuang, Liu, Yanyan, Ye, Ying, Sun, Rui, Li, Jiabin, Tian, Zhigang, Wei, Haiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786281/
https://www.ncbi.nlm.nih.gov/pubmed/33424840
http://dx.doi.org/10.3389/fimmu.2020.591269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786281/
https://www.ncbi.nlm.nih.gov/pubmed/33424840
http://dx.doi.org/10.3389/fimmu.2020.591269

Ejemplares similares